Vitiligo. Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Vitiligo disease with sympathetic involvement on both sides of the body
Exclusion criteria
Exclusion criteria: Photosynthetic Diseases Segmental vitiligo Autoimmune Disease Use of other vitiligo treatments such as topical corticosteroids and topical calcineurin. Patient with positive Kobner history and previous history of colloid formation pregnancy and lactation malignancy Infection at the injection site Severe ischemic heart disease, acute embolism, thrombophlebitis, gangrene, history of stroke renal failure hypertension Use of carbonic anhydrase inhibitors (acetazolamide, diclofenac) Decreased plasma protein levels in chronic hepatic failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin pigmentation of lesions. Timepoint: Before treatment and one month, two months, three months and four months after treatment. Method of measurement: Questionnaire designed by the researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kerman University of Medical Sciences